Enterprise Bank & Trust’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-23,124
| Closed | -$2.08M | – | 98 |
|
|
2022
Q1 | $2.08M | Sell |
23,124
-1,599
| -6% | -$144K | 0.82% | 42 |
|
|
2021
Q4 | $2.77M | Buy |
24,723
+279
| +1% | +$31.2K | 0.97% | 38 |
|
|
2021
Q3 | $3.07M | Sell |
24,444
-116
| -0.5% | -$14.6K | 1.21% | 30 |
|
|
2021
Q2 | $3.33M | Buy |
24,560
+401
| +2% | +$54.3K | 1.31% | 23 |
|
|
2021
Q1 | $3.28M | Buy |
24,159
+120
| +0.5% | +$16.3K | 1.38% | 20 |
|
|
2020
Q4 | $3.38M | Buy |
24,039
+1,769
| +8% | +$249K | 1.45% | 18 |
|
|
2020
Q3 | $2.48M | Sell |
22,270
-575
| -3% | -$64.1K | 1.17% | 28 |
|
|
2020
Q2 | $2.56M | Buy |
22,845
+287
| +1% | +$32.1K | 1.28% | 26 |
|
|
2020
Q1 | $1.75M | Sell |
22,558
-566
| -2% | -$43.8K | 1.03% | 31 |
|
|
2019
Q4 | $2.2M | Buy |
23,124
+916
| +4% | +$87.1K | 0.99% | 34 |
|
|
2019
Q3 | $1.69M | Buy |
22,208
+5,030
| +29% | +$383K | 0.82% | 41 |
|
|
2019
Q2 | $1.51M | Buy |
17,178
+1,869
| +12% | +$164K | 0.78% | 45 |
|
|
2019
Q1 | $1.39M | Buy |
+15,309
| New | +$1.39M | 0.57% | 53 |
|